Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) reported fourth quarter 2013 loss of 7 cents per share, in line with the Zacks Consensus Estimate, but wider than the year-ago loss of 3 cents per share. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock opened at $5.26 in last session, and closed at $5.95, while the day range of stock is $5.13- $6.11. The stock showed a positive/negative weekly performance of 4.75%.
Keryx Biopharmaceuticals (NASDAQ:KERX) reported a loss of 21 cents in the fourth quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 19 cents per share. The loss reported in the year-ago quarter was 9 cents per share. Keryx Biopharmaceuticals (NASDAQ:KERX) stock opened at $14.82, in last session and closed at $15.19,. The 52 week range of the stock is $6.61 – $17.07. Company’s market capitalization is $1.36 billion.
EVA Dimensions upgraded shares of Depomed (NASDAQ:DEPO) from an underweight rating to a hold rating in a report issued on Thursday, AR Network reports.Depomed Inc (NASDAQ:DEPO) stock finished the last session at $14.94. The EPS of the stock remained 0.74. Company’s market capitalization is $850.46 million.
Unilife Corp (NASDAQ:UNIS) announced it had received $60mm in financing from Orbimed, one of the most prestigious and well regarded Healthcare dedicated funds in the US. Unilife Corp (NASDAQ:UNIS) stock opened the session at $4.79, and closed the session at $4.99. The 52 week range of the stock remained $1.80 – $5.30 and the day range was $4.51- $5.11.
Leave a Reply